{"abstract": "With its best-selling drugs losing patent protection, Pfizer is shedding money-making but noncore businesses to focus on pharmaceutical sciences.", "web_url": "https://www.nytimes.com/2012/05/02/business/pfizer-profit-declines-19-after-loss-of-lipitor-patent.html", "snippet": "With its best-selling drugs losing patent protection, Pfizer is shedding money-making but noncore businesses to focus on pharmaceutical sciences.", "lead_paragraph": "For years, drug companies have known that their days of plenty were numbered, that the moment would arrive when the best-selling drugs that had driven two decades\u2019 worth of profits would lose their patent protection and succumb to competition from generic alternatives. Without new blockbusters to replace them, profits would tumble.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2012/05/02/business/JP-PFIZER-2/JP-PFIZER-2-jumbo.jpg", "height": 683, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2012/05/02/business/JP-PFIZER-2/JP-PFIZER-2-superJumbo.jpg", "height": 1366, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2012/05/02/business/JP-PFIZER-2/JP-PFIZER-2-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2012/05/02/business/JP-PFIZER-2/JP-PFIZER-2-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2012/05/02/business/JP-PFIZER-2/JP-PFIZER-2-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Pfizer Races to Reinvent Itself", "kicker": null, "content_kicker": null, "print_headline": "Pfizer Profit Declines 19% On Slumping Lipitor Sales", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Company Reports", "rank": 1, "major": "N"}, {"name": "subject", "value": "Inventions and Patents", "rank": 2, "major": "N"}, {"name": "subject", "value": "Lipitor (Drug)", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 4, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 5, "major": "N"}, {"name": "subject", "value": "Budgets and Budgeting", "rank": 6, "major": "N"}, {"name": "subject", "value": "Research", "rank": 7, "major": "N"}], "pub_date": "2012-05-02T01:37:09+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/333f5fc9-1337-5b7e-8cea-0c814002304d", "word_count": 1195, "uri": "nyt://article/333f5fc9-1337-5b7e-8cea-0c814002304d"}